Fig. 5From: ALDH1A3 serves as a predictor for castration resistance in prostate cancer patientsBEZ235 treatment rescued the resistance through PI3K pathway inhibition. a: Morphologic observation for BEZ235 treatment compared with the resistance phenotype. b: The growth curve documented the cell numbers of different groups, BEZ235 treatment rescued the ADT resistance in sg-ALDH1A3 groupBack to article page